To support a new phase of development in France and Europe, Destia is reorganizing its capital by welcoming new institutional investors. This transaction marks the entry of Bpifrance, Three Hills, Turenne Santé and VYV, and the reinvestment of its existing shareholders: Siparex ETI, majority shareholder since 2021, alongside BNP Paribas Développement, MACSF, Azulis, Après demain and Crédit Agricole.
Founded in 2006 by Xavier Mura, Destia is today the French leader in home care services for the elderly and people with disabilities. The group operates a network of 180 agencies in France and Europe and offers a comprehensive range of services promoting autonomy and wellbeing at home.
Beyond its core business, Destia offers inclusive housing solutions, has developed a training division dedicated to home care professions, and became an Entreprise à Mission in 2023, affirming its commitment to its beneficiaries, its teams, and the sector.
Since Siparex ETI joined in 2021, Destia has undergone a true change of scale. Revenue grew from €100M to over €250M in 2025, driven by sustained organic growth and more than 40 acquisitions, enabling the group to expand into Spain, Ireland, Germany and Switzerland.
This new shareholder structure aims to give Destia the means to embark on a new phase of development. The new shareholder pool, led by Siparex through its Siparex ETI strategy and the Mutuelles Impact fund, brings together Bpifrance, Three Hills, Turenne Santé, VYV, and the existing shareholders reinvesting on this occasion. It will support management in its ambition to accelerate agency openings and Destia's external growth strategy in France and Europe.
“This evolution of our shareholder base marks a new growth milestone for Destia. It brings together new partners and long-standing shareholders, loyal to our vision, with a shared ambition: to build the future of home care by placing our employees at the heart of the company's project. Because our greatest asset, and our primary driver of value creation, remains the commitment of those who support our beneficiaries every day.”
“We are very pleased to reaffirm, through this reinvestment, our confidence in Destia and its management team. Since 2021, Xavier Mura and his teams have demonstrated a remarkable ability to transform the group, execute acquisitions with discipline, and open new markets across Europe, while forging a distinctive identity — notably by becoming an Entreprise à Mission. We have built a top-tier shareholder base around Destia. This transaction represents a new strategic milestone in Destia's continued development journey.”
“Our entry into Destia's capital is fully in line with Bpifrance's mandate: addressing the major societal challenge of supporting people who have lost their autonomy at home. The challenge of an ageing population requires backing the development of quality service offerings by structured players. We are convinced that Destia operates the right model, and we look forward to supporting it in building European leadership”
- About XAnge - XAnge is a B Corp-certified early-stage investment fund with €800m under management and offices in Paris, Berlin and Brussels. The fund backs European founders aiming to transform everyday life through technology, investing between €1m and €15m from seed through Series C. XAnge is the venture capital brand of the Siparex group.
- About Mutuelles Impact - Created in 2020 at the initiative of Mutualité Française, managed by XAnge in partnership with Impactvist, Mutuelles Impact is the first impact fund dedicated to healthcare. Its objective is to invest in high-impact companies and support them in the areas of prevention, new care pathways, and medico-social services. With over €95m under management, the fund is backed by 64 French health insurers and 3 territorial actors (Banque des Territoires, Eurométropole de Strasbourg and e-Meuse santé).
- About Siparex - The Siparex Group is an independent French private equity specialist with nearly 50 years of experience. Through strong organic growth and significant acquisitions, Siparex manages over €4.4 billion in assets. The group supports companies in their growth and transformation. From startups to mid-sized enterprises, it finances and backs major entrepreneurial ventures through its different business lines: Private Equity, Venture Capital (XAnge) and Private Debt.
Siparex Press Contact: Agathe Pierrefitte – a.pierrefitte@siparex.com – +33 6 20 79 53 89 - About Bpifrance - Equity transactions are carried out by Bpifrance Investissement. Bpifrance finances companies — at every stage of their development — through loans, guarantees and equity. Bpifrance supports them in their innovation projects and international expansion. Bpifrance also covers their export activity through a wide range of products. Advisory services, training programs, networking and acceleration programs for startups, SMEs and mid-sized enterprises are also part of the offering provided to entrepreneurs.Through Bpifrance and its 50 regional offices, entrepreneurs benefit from a close, single and effective point of contact to help them meet their challenges.
Press contact: Sophie Santandrea – sophie.santandrea@bpifrance.fr – +33 7 88 09 28 17
